未解决的常染色体显性肾小管间质性肾病具有多样的分子病因
该研究对常染色体显性肾小管间质性肾病(ADTKD)登记队列行已知基因测序、MUC1 dupC小测序及肾病虚拟面板和外显子组测序,45个家系中29个发现已知ADTKD基因突变(多为MUC1),16个未解决家系中9个检出COL4A5、INF2等诊断性变异。
要点
- ADTKD登记家系中29/45个发现已知ADTKD基因突变,多数为MUC1突变。
- 16个未解决的ADTKD家系中9个检出其他肾病基因诊断性变异(如COL4A5、INF2)。
- 外显子组测序在其余7个家系中提示ADTKD新候选基因的潜在变异。
核心结论
- 大多数ADTKD登记家系可达分子遗传学诊断,但少数家系实为传统上归为肾小球疾病的病种。
- 临床表型不完整和非典型表现可能导致被归类为ADTKD。
- 外显子组测序鉴定的新候选基因需要进一步功能验证。
研究设计与样本
- 对ADTKD登记家系的已知ADTKD基因进行测序,随后对MUC1 dupC突变进行SNaPshot小测序。
- 随后依次分析包含560个肾病相关基因的虚拟面板(nephrome)和外显子组测序。
- 对变异进行验证并检测共分离。
主要发现
- 45个登记家系中29个发现已知ADTKD基因突变,多数为MUC1突变。
- 16个家系被归为ADTKD-未另行分类,其中9个在nephrome检出诊断性变异(COL4A5四个、INF2两个、COL4A4、PAX2、SALL1和PKD2各一个)。
- 其余7个家系经外显子组测序分析获得ADTKD新候选基因的潜在疾病相关变异,并通过数据库分析和全基因组关联研究评估。
关键数值与推荐
- 45个登记家系中29个发现已知ADTKD基因突变(多数为MUC1)。
- 16个未解决家系中9个检出诊断性变异:COL4A5四个、INF2两个、COL4A4一个、PAX2一个、SALL1一个、PKD2一个。
- 其余7个家系的外显子组测序提示ADTKD新候选基因的潜在疾病相关变异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 少数家系实为传统上归为肾小球疾病的病种,临床表型不完整和非典型表现可能导致被归类为ADTKD。
- 外显子组测序鉴定的新候选基因需要进一步功能验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) is caused by mutations in one of at least five genes and leads to kidney failure usually in mid adulthood. Throughout the literature, variable numbers of families have been reported, where no mutation can be found and therefore termed ADTKD-not otherwise specified. Here, we aim to clarify the genetic cause of their diseases in our ADTKD registry. Sequencing for all known ADTKD genes was performed, followed by SNaPshot minisequencing for the dupC (an additional cytosine within a stretch of seven cytosines) mutation of MUC1. A virtual panel containing 560 genes reported in the context of kidney disease (nephrome) and exome sequencing were then analyzed sequentially. Variants were validated and tested for segregation. In 29 of the 45 registry families, mutations in known ADTKD genes were found, mostly in MUC1. Sixteen families could then be termed ADTKD-not otherwise specified, of which nine showed diagnostic variants in the nephrome (four in COL4A5, two in INF2 and one each in COL4A4, PAX2, SALL1 and PKD2). In the other seven families, exome sequencing analysis yielded potential disease associated variants in novel candidate genes for ADTKD; evaluated by database analyses and genome-wide association studies. For the great majority of our ADTKD registry we were able to reach a molecular genetic diagnosis. However, a small number of families are indeed affected by diseases classically described as a glomerular entity. Thus, incomplete clinical phenotyping and atypical clinical presentation may have led to the classification of ADTKD. The identified novel candidate genes by exome sequencing will require further functional validation.
引用
- Wopperer FJ, Knaup KX, Stanzick KJ, et al. Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases. Kidney Int. 2022. PMID: 35643372. doi:10.1016/j.kint.2022.04.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。